全身免疫化疗治疗肝癌的效果

被引：10

作者：

刘允怡 ^{[1
]}

赖俊雄 ^{[1
]}

梁惠棠 ^{[2
]}

机构：

[1] 香港中文大学威尔斯亲王医院外科学系

[2] 香港养和医院综合肿瘤科中心

来源：

中国普外基础与临床杂志 | 2006年 / 02期

关键词：

肝癌; 全身免疫化疗; 免疫治疗; 化疗; 手术切除;

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

引用

页码：129 / 131

页数：3

共 6 条

[1]

Cure is Possible with Salvage Surgery following Downstaging of Hepatocellular Carcinoma.[J].W.Y. Lau.Chinese-German journal of clinical oncology.2004, 3

[2]

Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial [J].

Feun, LG ;

O'Brien, C ;

Molina, E ;

Rodriguez, M ;

Jeffers, L ;

Schiff, ER ;

Marini, A ;

Savaraj, N ;

Ardalan, B .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (01) :17-20

[3]

No synergistic activity of epirubicin and interferon-α2b in the treatment of hepatocellular carcinoma.[J].Carsten Bokemeyer;Bernd Kynast;Andreas Harstrick;Ebba Laage;Ekkhard Schmoll;Peter Wussow;Hans-Joachim Schmoll.Cancer Chemotherapy and Pharmacology.1995, 4

[4]

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma..Llovet JM; Sala M; Castells L; et al;.Hepatology.2000,

[5]

PhaseⅡtrial of sys-temic continuous fluorouracil and subcutaneous recombinant in-terferon Alfa-2b for treatment of hepatocellular carcinoma..Patt YZ;Hassan MM;Lozano RD;et al;.J Clin Oncol.2003,

[6]

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination Cisplatin; interferon-alpha; doxorubicin and 5-fluorouracil chemotherapy..Leung TW; Tang AM; Zee B; et al;.Cancer.2002,

← 1 →